Melanoma - Pipeline Review, H1 2016 - Global Markets Direct - Market Research

Melanoma - Pipeline Review, H1 2016

Melanoma - Pipeline Review, H1 2016 - Global Markets Direct - Market Research
Melanoma - Pipeline Review, H1 2016
Published Jun 30, 2016
1479 pages — Published Jun 30, 2016
Price US$ 2,500.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Global Markets Directs, Melanoma - Pipeline Review, H1 2016, provides an overview of the Melanoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Melanoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Melanoma and features dormant and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the global therapeutic landscape of Melanoma
- The report reviews pipeline therapeutics for Melanoma by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved Melanoma therapeutics and enlists all their major and minor projects
- The report assesses Melanoma therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Melanoma

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Melanoma
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Melanoma pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying

  
Source:
Document ID
GMDHC7955IDB
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents263
  List of Tables568
  List of Figures641
Introduction651
  Global Markets Direct Report Coverage651
Melanoma Overview661
Therapeutics Development672
  Pipeline Products for Melanoma Overview671
  Pipeline Products for Melanoma Comparative Analysis681
Melanoma Therapeutics under Development by Companies6921
Melanoma Therapeutics under Investigation by Universities/Institutes904
Melanoma Pipeline Products Glance944
  Late Stage Products941
  Clinical Stage Products951
  Early Stage Products961
  Unknown Stage Products971
Melanoma Products under Development by Companies9828
Melanoma Products under Investigation by Universities/Institutes1266
Melanoma Companies Involved in Therapeutics Development132239
  4SC AG1321
  AB Science SA1331
  AbbVie Inc.1341
  ACF Pharmaceuticals, LLC1351
  Adamis Pharmaceuticals Corporation1361
  Adaptimmune Therapeutics Plc1371
  Adicet Bio, Inc.1381
  Aduro BioTech, Inc.1391
  Advaxis, Inc.1401
  Aeterna Zentaris Inc.1411
  Affichem SA1421
  Agalimmune Ltd1431
  Agenus, Inc.1441
  Agilvax, Inc.1451
  AGV Discovery, SAS1461
  AIMM Therapeutics B.V.1471
  Alethia Biotherapeutics Inc.1481
  Altor BioScience Corporation1491
  Amgen Inc.1501
  Anavex Life Sciences Corp.1511
  Angimmune LLC1521
  Antibe Therapeutics, Inc.1531
  Antigen Express, Inc.1541
  APEIRON Biologics AG1551
  Apexigen, Inc.1561
  Aphios Corporation1571
  APO-T B.V.1581
  Apogenix GmbH1591
  Aposense Ltd.1601
  Aptose Biosciences Inc.1611
  Arisaph Pharmaceuticals, Inc.1621
  Array BioPharma Inc.1631
  Asana BioSciences, LLC1641
  Astex Pharmaceuticals, Inc.1651
  AstraZeneca Plc1661
  Aurigene Discovery Technologies Limited1671
  Azaya Therapeutics, Inc.1681
  Basilea Pharmaceutica AG1691
  Batu Biologics, Inc.1701
  Bayer AG1711
  BeiGene, Ltd.1721
  Beijing Kawin Technology Share-Holding Co., Ltd.1731
  Bellicum Pharmaceuticals, Inc.1741
  Bio-Cancer Treatment International Limited1751
  BioApex, s.r.o.1761
  BIOCAD1771
  Biogazelle1781
  Biogenomics Limited1791
  BioLineRx, Ltd.1801
  Bioncotech Therapeutics S.L.1811
  Bionomics Limited1821
  BioNTech AG1831
  Bioo Therapeutics1841
  Biovista Inc.1851
  Boehringer Ingelheim GmbH1861
  Boston Biomedical, Inc.1871
  Bristol-Myers Squibb Company1881
  Calithera Biosciences, Inc.1891
  Can-Fite BioPharma Ltd.1901
  CCRP Therapeutics GmbH1911
  Cellceutix Corporation1921
  Celldex Therapeutics, Inc.1931
  Celprogen, Inc.1941
  Celyad SA1951
  Chipscreen Biosciences Ltd1961
  Cipher Pharmaceuticals Inc.1971
  Cornerstone Pharmaceuticals, Inc.1981
  Cortice Biosciences, Inc.1991
  Corvus Pharmaceuticals, Inc.2001
  Cytune Pharma SAS2011
  CyTuVax B.V.2021
  CZ BioMed Corp2031
  Daiichi Sankyo Company, Limited2041
  Deciphera Pharmaceuticals, LLC2051
  Delcath Systems, Inc.2061
  Dicerna Pharmaceuticals, Inc.2071
  Digna Biotech, S.L.2081
  DormaTarg, Inc.2091
  Dynavax Technologies Corporation2101
  Eisai Co., Ltd.2111
  Eli Lilly and Company2121
  Elsalys Biotech SAS2131
  Ensol Biosciences Inc.2141
  EntreChem, S.L.2151
  Erytech Pharma SA2161
  eTheRNA Immunotherapies NV2171
  Exelixis, Inc.2181
  F. Hoffmann-La Roche Ltd.2191
  Faes Farma, S.A.2201
  FirstString Research, Inc.2211
  Five Prime Therapeutics, Inc.2221
  Formune S.L.2231
  Galapagos NV2241
  Galectin Therapeutics, Inc.2251
  Genelux Corporation2261
  Genzyme Corporation2271
  GlaxoSmithKline Plc2281
  Gradalis Inc.2291
  GreenPeptide Co., Ltd.2301
  Hadasit Medical Research Services &Development Ltd2311
  Hanmi Pharmaceuticals, Co. Ltd.2321
  Heat Biologics, Inc.2331
  HEC Pharm Co., Ltd.2341
  Histogen, Inc.2351
  Horizon Pharma Plc2361
  Idera Pharmaceuticals, Inc.2371
  Ignyta, Inc.2381
  Immodulon Therapeutics Ltd.2391
  Immune Design Corp.2401
  Immune Response BioPharma, Inc.2411
  ImmunGene, Inc.2421
  Immunocore Limited2431
  ImmunoFrontier, Inc.2441
  ImmunoGen, Inc.2451
  Immunomic Therapeutics, Inc.2461
  Immupharma Plc2471
  ImmuRx, Inc.2481
  IMPACT Therapeutics, Inc.2491
  Imugene Limited2501
  Incuron, LLC2511
  Incyte Corporation2521
  Infinity Pharmaceuticals, Inc.2531
  Inovio Pharmaceuticals, Inc.2541
  InteRNA Technologies B.V.2551
  IO Biotech ApS2561
  JHL Biotech, Inc.2571
  Jiangsu Hengrui Medicine Co., Ltd.2581
  KaloBios Pharmaceuticals, Inc.2591
  Kancera AB2601
  Karyopharm Therapeutics, Inc.2611
  Kite Pharma, Inc.2621
  Kolltan Pharmaceuticals, Inc.2631
  Kura Oncology, Inc.2641
  Kuros Biosciences AG2651
  Life Science Pharmaceuticals, Incorporated2661
  Lindis Biotech GmbH2671
  Lipotek Pty Ltd.2681
  Loxo Oncology, Inc.2691
  Luitpold Pharmaceuticals, Inc.2701
  Lytix Biopharma AS2711
  MacroGenics, Inc.2721
  Magnus Life Science2731
  MaxiVAX SA2741
  MediaPharma s.r.l.2751
  MedImmune, LLC2761
  Medisyn Technologies, Inc.2771
  Medivation, Inc.2781
  MELEMA Pharma GmbH2791
  Merck &Co., Inc.2801
  Merck KGaA2811
  Millennium Pharmaceuticals, Inc.2821
  Mirna Therapeutics, Inc.2831
  Modulate Therapeutics, Inc.2841
  Molecular Templates Inc.2851
  Mologen AG2861
  Morphotek, Inc.2871
  Nektar Therapeutics2881
  Nerviano Medical Sciences S.r.l.2891
  Neumedicines Inc.2901
  NewLink Genetics Corporation2911
  NormOxys, Inc.2921
  Northwest Biotherapeutics, Inc.2931
  Novartis AG2941
  Novogen Limited2951
  Omeros Corporation2961
  Oncology Research International Limited2971
  Oncolys BioPharma Inc.2981
  Oncolytics Biotech Inc.2991
  OncoNOx ApS3001
  OncoSec Medical Incorporated3011
  OncoTartis, Inc.3021
  Oncovir, Inc.3031
  Onxeo SA3041
  OPKO Health, Inc.3051
  Pacific Northwest Biotechnology, LLC3061
  PepTx, Inc.3071
  Pfizer Inc.3081
  Pharmicell Co., Ltd.3091
  Pharminox Limited3101
  Pharmis Biofarmaceutica, Lda.3111
  Philogen S.p.A.3121
  PinCell srl3131
  Pivotal BioSciences, Inc.3141
  Plexxikon Inc.3151
  Polaris Pharmaceuticals, Inc.3161
  Prima BioMed Ltd.3171
  Provectus Biopharmaceuticals, Inc.3181
  Provenance Biopharmaceuticals Corp.3191
  Qu Biologics Inc.3201
  Reata Pharmaceuticals, Inc.3211
  Recepta Biopharma S.A.3221
  Recombio S.L3231
  Rexahn Pharmaceuticals, Inc.3241
  Rgenix, Inc.3251
  Rigontec GmbH3261
  RXi Pharmaceuticals Corporation3271
  Sapvax3281
  Satt Nord SAS3291
  Scancell Holdings Plc3301
  Sillajen Biotherapeutics3311
  SK Biopharmaceuticals Co., Ltd.3321
  Sorrento Therapeutics, Inc.3331
  Sumitomo Dainippon Pharma Co., Ltd.3341
  Sun Pharma Advanced Research Company Ltd.3351
  Susavion Biosciences, Inc.3361
  SuviCa Inc.3371
  Syndax Pharmaceuticals, Inc.3381
  Synta Pharmaceuticals Corp.3391
  Taiga Biotechnologies, Inc.3401
  TaiRx, Inc.3411
  Taiwan Liposome Company, Ltd.3421
  Takara Bio Inc.3431
  Takeda Pharmaceutical Company Limited3441
  Takis S.r.l.3451
  Targovax AS3461
  TC BioPharm Limited3471
  TetraLogic Pharmaceuticals3481
  Teva Pharmaceutical Industries Ltd.3491
  Theravectys SA3501
  Theryte Limited3511
  Tikcro Technologies, Ltd.3521
  Tiltan Pharma Ltd.3531
  Tocagen Inc.3541
  TREAT U, S.A.3551
  TVAX Biomedical, Inc.3561
  TyrNovo Ltd.3571
  UbiVac, LLC3581
  Ultimovacs AS3591
  UNC Health Care3601
  Vaccibody AS3611
  Vascular Biogenics Ltd.3621

Table Of Contents

Global Markets Direct - Market Research—Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.

About the Author


Cite this Report

  
MLA:
Global Markets Direct - Market Research. "Melanoma - Pipeline Review, H1 2016" Jun 30, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/Melanoma-Pipeline-Review-H1-2016-2088-16061>
  
APA:
Global Markets Direct - Market Research. (2016). Melanoma - Pipeline Review, H1 2016 Jun 30, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/Melanoma-Pipeline-Review-H1-2016-2088-16061>
  
US$ 2,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.